This site is intended for health professionals only

Published on 2 July 2007

Share this story:

Belgian firm’s CFO to quit


Brussels-based drug company UCB has announced that executive vice-president and chief financial officer Mr Luc Missorten will leave the company on 1 September 2007.

Mr Missorten joined UCB in February 2004 as general manager of UCB Pharma Spain and was appointed chief financial officer in November 2004.

UCB is a biopharmaceutical company researching, developing and commercialising pharmaceutical and biotechnology products in the fields of central nervous system disorders, allergy/respiratory diseases, immune and inflammatory disorders and oncology. It owns 87.6% of Schwarz Pharma.

Press release 2/7/2007


Most read

Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine